Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Cancer Research

Local and Abscopal Responses in Advanced Intrahepatic Cholangiocarcinoma With Low TMB, MSS, pMMR and Negative PD-L1 Expression Following Combined Therapy of SBRT With PD-1 Blockade

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Human Double Negative T Cells Target Lung Cancer via Ligand-Dependent Mechanisms That Can Be Enhanced by IL-15

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Human Hybridoma and Recombinant Pritumumab Antibodies for Treatment of Human Solid Tumors

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Il-6 Is Non-Essential to Murine CD19 CAR Efficacy, but Can Mediate Acute GVHD Following Allogeneic BMT With CAR T Cell Infusion

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Elucidating the Role of Neuropilin-1 in Intra-Tumoral Regulatory T Cell Stability

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Identification of Circulatory Biomarkers From Clinical Trial Samples

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Systemic Immunotherapy of Superficial Mouse Bladder Cancer With Avelumab (MSB0010718C), an Anti-Pd-L1 Immune Checkpoint Inhibitor

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

P52. A New Pathway of Tumour Antigen Loading of Human Dendritic Cells via Intercellular Communication

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Active8: A Randomized, Double-Blind, Placebo-Controlled Study of Chemotherapy Plus Cetuximab in Combination With TLR8 Agonist VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

IL-15 Is an Inflammatory Mediator in the Tumor Microenvironment

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy